Major Pharmaceutical Conferences and Courses: August to September 2023.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 261, doi. 10.1007/s40290-023-00476-w
- Publication type:
- Article
Works matching IS 11782595 AND DT 2023 AND VI 37 AND IP 3
Results: 8
1
2
Black-Box Warnings of Antiseizure Medications: What is Inside the Box?
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 233, doi. 10.1007/s40290-023-00475-x
- By:
- Publication type:
- Article
3
Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 203, doi. 10.1007/s40290-023-00473-z
- By:
- Publication type:
- Article
4
Evaluation of Risk-Based Approaches to the Registration of Medicines: Current Status Among African Regulatory Authorities.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 251, doi. 10.1007/s40290-023-00472-0
- By:
- Publication type:
- Article
5
How Digital Opinion Leaders (DOLs) in Clinical Care are Changing the Medical Landscape.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 215, doi. 10.1007/s40290-023-00471-1
- By:
- Publication type:
- Article
6
Value and Implementation of the Aggregate Safety Assessment Plan.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 171, doi. 10.1007/s40290-023-00470-2
- By:
- Publication type:
- Article
7
Designing Clinical Trials to Assess the Impact of Pharmacological Treatment for Suicidal Ideation/Behavior: Issues and Potential Solutions.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 221, doi. 10.1007/s40290-023-00467-x
- By:
- Publication type:
- Article
8
A Science-Based Methodology Framework for the Assessment of Combination Safety Risks in Clinical Trials.
- Published in:
- Pharmaceutical Medicine, 2023, v. 37, n. 3, p. 183, doi. 10.1007/s40290-023-00465-z
- By:
- Publication type:
- Article